Aytu Biopharma (AYTU) Short term Debt (2019 - 2026)
Aytu Biopharma (AYTU) recorded Short term Debt of $6.07 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 33.0% from $9.06 million a year earlier and down 41.7% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Short term Debt (2019 - 2026) Analysis & Trends
Starting with fiscal Q2 2020, Aytu Biopharma's Short term Debt history includes 27 quarters.
- Annual Short term Debt has a five-year compound annual growth rate of -18.3% (FY2021 to FY2026).
- Across earlier fiscal years, Short term Debt came in at $9.06 million in FY2025 (+278.4%), $2.4 million in FY2024, $85,000 in FY2023 (-11.5%) and $96,000 in FY2022 (-99.4%).
- The fiscal Q4 2026 figure is the lowest quarterly Short term Debt since fiscal Q2 2025.
- On a year-over-year basis, Short term Debt rose in four of the last six quarters, with growth averaging 217.5%.
- Peak year-over-year performance for Short term Debt in the last five years was growth of 743.5% in fiscal Q2 2022, against a decline of 99.4% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $10.41 million (Q3 2026), $9.08 million (Q2 2026) and $14.87 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.07 Mn |
| Mar 31, 2026 | 10.41 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 14.87 Mn |
| Jun 30, 2025 | 9.06 Mn |
| Mar 31, 2025 | 10.03 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 15.14 Mn |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 3.31 Mn |
| Dec 31, 2022 | 90,000.00 |
| Sep 30, 2022 | 8.09 Mn |
| Jun 30, 2022 | 96,000.00 |
| Mar 31, 2022 | 3.39 Mn |
| Dec 31, 2021 | 16.34 Mn |
| Sep 30, 2021 | 16.51 Mn |
API Access
Aytu Biopharma Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();